The Asia Pacific Digital Therapeutics Market would witness market growth of 23.2% CAGR during the forecast period (2021-2027). Digital therapeutics refers to healthcare solution and treatment option, which uses digital technologies to cure patients with any kind of medical or psychological problem. It offers a whole new approach for the treatment and disease management under which it uses systems & high-quality software to assist patients to monitor their health conditions at home.
In addition, these solutions use internet infrastructure, smartphones, and certain advanced technologies like artificial intelligence (AI), machine learning, and big data analytics to maximize the treatment for a patient, thus implementing the principle of customized medicine. The digital therapeutics market consists of a wide variety of products like telemedicine platforms, apps, wearable devices, and others. In present scenario, there are many healthcare apps and wearable devices which are easily accessible all over the world.
Advancements in technologies in developing countries are estimated to spur the demand for the digital therapeutics market. It is due to the increasing disposable income, use of the internet, and mobile & other smart devices. In addition, a rising number of healthcare applications and wearable gadgets have contributed to connecting the world via a different range of applications. All these technological improvements will further open new growth avenues for the digital therapeutics market during the forecast period. Moreover, the increasing government initiatives & programs to protect the healthy population are also expected to support the demand for the digital therapeutics market over the years. Developing countries are adopting various technological advancements that further help the market to grow.
The Diabetes market dominated the South Korea Digital Therapeutics Market by Applications 2020, thereby, achieving a market value of $90.2 million by 2027. The CNS Disease market is estimated to grow at a CAGR of 27% during (2021 - 2027). The Respiratory Diseases market is showcasing a CAGR of 28.3% during (2021 - 2027). Additionally, The Smoking Cessation market is expected to witness a CAGR of 27.7% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Digital Therapeutics Market is Projected to reach USD 14.5 Billion by 2027, at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
By Application
- Diabetes
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Obesity
- CVD
- others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- ResMed, Inc. (Propeller Health)
- Teladoc Health, Inc. (Livongo Health)
- Noom, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Canary Health
- Mango Health, Inc. (TrialCard, Incorporated)
- 2Morrow, Inc.
- Pear Therapeutics, Inc.
- Mindstrong, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Digital Therapeutics Market, by End Use
1.4.2 Asia Pacific Digital Therapeutics Market, by Application
1.4.3 Asia Pacific Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. Asia Pacific Digital Therapeutics Market by End Use
4.1 Asia Pacific Patients Market by Country
4.2 Asia Pacific Providers Market by Country
4.3 Asia Pacific Payers Market by Country
4.4 Asia Pacific Employers Market by Country
4.5 Asia Pacific Other End Use Market by Country
Chapter 5. Asia Pacific Digital Therapeutics Market by Applications
5.1 Asia Pacific Diabetes Applications Market by Country
5.2 Asia Pacific CNS Disease Applications Market by Country
5.3 Asia Pacific Respiratory Diseases Applications Market by Country
5.4 Asia Pacific Smoking Cessation Applications Market by Country
5.5 Asia Pacific Obesity Applications Market by Country
5.6 Asia Pacific CVD Applications Market by Country
5.7 Asia Pacific Other Applications Market by Country
Chapter 6. Asia Pacific Digital Therapeutics Market by Country
6.1 China Digital Therapeutics Market
6.1.1 China Digital Therapeutics Market by End Use
6.1.2 China Digital Therapeutics Market by Applications
6.2 Japan Digital Therapeutics Market
6.2.1 Japan Digital Therapeutics Market by End Use
6.2.2 Japan Digital Therapeutics Market by Applications
6.3 India Digital Therapeutics Market
6.3.1 India Digital Therapeutics Market by End Use
6.3.2 India Digital Therapeutics Market by Applications
6.4 South Korea Digital Therapeutics Market
6.4.1 South Korea Digital Therapeutics Market by End Use
6.4.2 South Korea Digital Therapeutics Market by Applications
6.5 Singapore Digital Therapeutics Market
6.5.1 Singapore Digital Therapeutics Market by End Use
6.5.2 Singapore Digital Therapeutics Market by Applications
6.6 Malaysia Digital Therapeutics Market
6.6.1 Malaysia Digital Therapeutics Market by End Use
6.6.2 Malaysia Digital Therapeutics Market by Applications
6.7 Rest of Asia Pacific Digital Therapeutics Market
6.7.1 Rest of Asia Pacific Digital Therapeutics Market by End Use
6.7.2 Rest of Asia Pacific Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Digital Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Digital Therapeutics Market
TABLE 5 Business Expansions– Digital Therapeutics Market
TABLE 6 Acquisition and Mergers– Digital Therapeutics Market
TABLE 7 Asia Pacific Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Patients Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Patients Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Providers Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Providers Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Payers Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Payers Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Employers Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Employers Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Other End Use Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Other End Use Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Diabetes Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Diabetes Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 Asia Pacific CNS Disease Applications Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific CNS Disease Applications Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
TABLE 29 Asia Pacific Obesity Applications Market by Country, 2017 - 2020, USD Million
TABLE 30 Asia Pacific Obesity Applications Market by Country, 2021 - 2027, USD Million
TABLE 31 Asia Pacific CVD Applications Market by Country, 2017 - 2020, USD Million
TABLE 32 Asia Pacific CVD Applications Market by Country, 2021 - 2027, USD Million
TABLE 33 Asia Pacific Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 34 Asia Pacific Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 35 Asia Pacific Digital Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 36 Asia Pacific Digital Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 37 China Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 38 China Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 39 China Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 40 China Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 41 China Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 42 China Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 43 Japan Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 44 Japan Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 45 Japan Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 46 Japan Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 47 Japan Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 48 Japan Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 49 India Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 50 India Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 51 India Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 52 India Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 53 India Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 54 India Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 55 South Korea Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 56 South Korea Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 57 South Korea Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 58 South Korea Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 59 South Korea Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 60 South Korea Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 61 Singapore Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 62 Singapore Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 63 Singapore Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 64 Singapore Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 65 Singapore Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 66 Singapore Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 67 Malaysia Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 68 Malaysia Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 69 Malaysia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 70 Malaysia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 71 Malaysia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 72 Malaysia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 73 Rest of Asia Pacific Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 74 Rest of Asia Pacific Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 75 Rest of Asia Pacific Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 76 Rest of Asia Pacific Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 77 Rest of Asia Pacific Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 78 Rest of Asia Pacific Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 79 Key Information – ResMed, Inc.
TABLE 80 Key Information – Teladoc Health, Inc.
TABLE 81 key information – Noom, Inc.
TABLE 82 Key Information – Omada Health, Inc.
TABLE 83 key Information – Welldoc, Inc.
TABLE 84 Key Information – Canary Health
TABLE 85 key information – Mango Health, Inc.
TABLE 86 Key Information – 2Morrow, Inc.
TABLE 87 Key Information – Pear Therapeutics, Inc.
TABLE 88 Key Information – Mindstrong, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
FIG 5 Recent strategies and developments: Teladoc Health, Inc.
FIG 6 Recent strategies and developments: Omada Health, Inc.
FIG 7 Recent strategies and developments: Canary Health
FIG 8 Recent strategies and developments: Pear Therapeutics, Inc.